Biocon Targets GLP-1s In MENA With Tabuk Tie-Up
Fresh Deal For Diabetes And Weight Products Builds On Existing Alliance Between Firms
Executive Summary
Biocon has struck a deal that will see its GLP-1 diabetes and chronic weight management products commercialized in the Middle East region by partner Tabuk Pharmaceutical.